1,009 results on '"Gebo, Kelly A"'
Search Results
152. Predictors of Highly Active Antiretroviral Therapy Utilization for Behaviorally HIV-1–Infected Youth: Impact of Adult Versus Pediatric Clinical Care Site
153. Risk Factors for Tuberculosis After Highly Active Antiretroviral Therapy Initiation in the United States and Canada: Implications for Tuberculosis Screening
154. Geographic Variation in Obesity at the State Level in the All of Us Research Program
155. Time Between Viral Loads for People with HIV during the COVID-19 Pandemic
156. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
157. Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection
158. The Economic Burden of Late Entry Into Medical Care for Patients With HIV Infection
159. Trends in Multidrug Treatment Failure and Subsequent Mortality among Antiretroviral Therapy–Experienced Patients with HIV Infection in North America
160. Racial and Sex Disparities in Life Expectancy Losses among HIV-Infected Persons in the United States: Impact of Risk Behavior, Late Initiation, and Early Discontinuation of Antiretroviral Therapy
161. HIV infection in older people
162. Lumbar Puncture in HIV-Infected Patients with Syphilis and No Neurologic Symptoms
163. PUBLIC HEALTH STUDIES AS AN UNDERGRADUATE MAJOR
164. Rate of Comorbidities Not Related to HIV Infection or AIDS among HIV-Infected Patients, by CD4 Cell Count and HAART Use Status
165. Workshop on HIV Infection and Aging: What Is Known and Future Research Directions
166. Antiretroviral Therapy Is Associated with Reduced Serologic Failure Rates for Syphilis among HIV-Infected Patients
167. The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States
168. The shifting age distribution of people with HIV using antiretroviral therapy in the United States
169. 444. County-level COVID-19 Case Fatality Rate in Medicaid Expansion States Compared to Non-Expansion States
170. 48. Time Between Viral Loads for Suppressed and Non-Suppressed People with HIV During the COVID-19 Pandemic Compared to Pre-Pandemic
171. Telemedicine and visit completion among people with HIV during the coronavirus disease 2019 pandemic compared with prepandemic
172. Pediatric data from the All of Us research program: demonstration of pediatric obesity over time
173. Immunologic Function and Virologic Suppression Among Children With Perinatally Acquired HIV Infection on Highly Active Antiretroviral Therapy
174. High Rates of Primary Mycobacterium avium Complex and Pneumocystis jiroveci Prophylaxis in the United States
175. Hospital and Outpatient Health Services Utilization Among HIV-Infected Adults in Care 2000–2002
176. Hospital and Outpatient Health Services Utilization Among HIV-Infected Children in Care 2000–2001
177. Patterns of Diagnoses in Hospital Admissions in a Multistate Cohort of HIV-Positive Adults in 2001
178. The Impact of Youth-Friendly Structures of Care on Retention Among HIV-Infected Youth
179. Racial, ethnic, and gender differences in obesity and body fat distribution: An All of Us Research Program demonstration project
180. Epidemiology of Atrial Fibrillation in theAll of UsResearch Program
181. Predictive Analytics for Glaucoma Using Data From the All of Us Research Program
182. Progress With the All of Us Research Program
183. Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020
184. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
185. Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years
186. Resource utilization across the continuum of HIV care: An emergency department-based cohort study
187. Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005–2015
188. The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities
189. Risk Factors for Pneumococcal Disease in Human Immunodeficiency Virus-Infected Patients
190. Substance abuse treatment in human immunodeficiency virus: The role of patient–provider discussions
191. Predicting Direct Costs of HIV Care During the First Year of Darunavir-Based Highly Active Antiretroviral Therapy Using CD4 Cell Counts: Evidence from POWER
192. HIV infection in the elderly
193. P213: Lack of detectable antibodies to mpox in infected individuals.
194. Effect of early versus deferred antiretroviral therapy for HIV on survival
195. Impact of Patient Race on Patient Experiences of Access and Communication in HIV Care
196. The shifting age distribution of people with HIV using antiretroviral therapy in the United States.
197. Telemedicine and visit completion among people with HIV during the coronavirus disease 2019 pandemic compared with prepandemic.
198. Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
199. Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes
200. Structures of care in the clinics of the HIV Research Network
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.